Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. is a pharmaceutical company based in China focused on the development, import, and export of medications and health products. Specializing in Heparin sodium and low molecular weight heparin, the company operates primarily within China while exporting to European and American markets. With an ESG score of 42.5, Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. faces severe risk in its industry.